The post Solana Company Moves Forward with Resale Registration, HSDT Drops 12% appeared first on Coinpedia Fintech News A Solana Treasury company has recently announced a bold step that sets it apart from other DATs. Solana Company, formerly known as Helius Medical Technologies, has announced that it will move forward with making its resale registration effective, a process that lets early investors sell restricted shares on the open market. The company said that …The post Solana Company Moves Forward with Resale Registration, HSDT Drops 12% appeared first on Coinpedia Fintech News A Solana Treasury company has recently announced a bold step that sets it apart from other DATs. Solana Company, formerly known as Helius Medical Technologies, has announced that it will move forward with making its resale registration effective, a process that lets early investors sell restricted shares on the open market. The company said that …

Solana Company Moves Forward with Resale Registration, HSDT Drops 12%

2025/10/21 17:16
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Canary Capital

The post Solana Company Moves Forward with Resale Registration, HSDT Drops 12% appeared first on Coinpedia Fintech News

A Solana Treasury company has recently announced a bold step that sets it apart from other DATs.

Solana Company, formerly known as Helius Medical Technologies, has announced that it will move forward with making its resale registration effective, a process that lets early investors sell restricted shares on the open market. The company said that it’s playing “offense”, emphasizing its commitment to growth.

Instead of delaying its scheduled registration for the resale of shares purchased during the recent private placement, the company chose to move forward as planned, while similar firms are holding back amid market uncertainty. 

The company says is taking a “rip off the band-aid” approach, hoping that this will help create market equilibrium for HSDT and support better long-term price discovery.

What does this mean for HSDT?

The company notes that on the next phase, with the resale registration statement effective, HSDT will rank among the largest Solana DATs by effective market cap, making it an attractive option for institutional investors seeking exposure to Solana.

“The pressure on our stock price that comes with the effectiveness of the resale registration statement will likely shake out weak hands, but we believe this will also establish a remaining foundation of committed long-term shareholders,” Executive Chairman Joseph Chee said in a statement.

The firm also clarified that if HSDT trades below its net asset value in the days ahead, that simply means investors have the chance to buy one dollar of Solana for less than a dollar.

Building the “Berkshire Hathaway of the Solana ecosystem”

The company plans to show how HSDT can actively accumulate Solana, buying more SOL per share than most investors could on their own. It aims to generate 7%+ yield through institutional-grade staking, not available to individual investors. It also plans to use the capital markets to acquire more Solana and deploy capital strategically during market dislocations.

“When the non-believers are flushed out, HSDT can continue to accrete Solana per share. We can buy aggressively when others are fearful. We believe we can compound Solana per share holdings through disciplined capital allocation,” Chee said. 

Solana Company aims to be the “Berkshire Hathaway of Solana,” growing shareholder value with a strong balance sheet and experienced leadership.

Lately, PIPEs (Private placement in a public equity deals), have become a popular way for new digital asset treasury firms to quickly raise capital and build cryptocurrency holdings. However, some firms saw their stock prices drop sharply once PIPE shares started trading, raising questions about whether the approach works long-term in crypto markets.

HSDT Drops 12%

HSDT is down about 12% over the past day and is currently trading at $6.87. Earlier this month, Solana Company revealed that it has partnered with Coinbase, BitGo, and Anchorage Digital as custodians for its growing Solana (SOL) treasury.

Market Opportunity
Movement Logo
Movement Price(MOVE)
$0.02128
$0.02128$0.02128
-0.65%
USD
Movement (MOVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09